Disease outbreaks are fast, frequent and unpredictable.
The vaccines to fight them are slow and difficult to develop.
A hypothetical flu-like pandemic could spread very quickly and, without a vaccine, could result in 30m deaths in 12 months – the same as the population of Malaysia. How many lives could be saved with a speedily deployed vaccine?
What if we restrict travel by 50% or introduce the vaccine after:
Number of deaths
Total deaths averted: 0
Winning the race
How vaccine innovation could outpace the spread of global diseases
and sequence the new DNA/RNA vaccine
Researcher analyzes material from the outbreak pathogen and purifies the genetic material.
Genetic material is sequenced and code uploaded to the cloud.
Enables researchers everywhere to work on developing DNA/RNA vaccines.
the vaccine to ensure safety and efficacy
Standardized methods of vaccine production and past studies with the same vaccine platform could accelerate the evaluation of vaccines.
This ensures they are quickly evaluated, reviewed and approved.
enough of the vaccine as and when you need to
Standardized production methods could mean the rapid development of a vaccine stockpile.
This would play a critical role protecting first responders and interrupting virus transmission in the general population.
the vaccine to outpace pandemics
Accelerating vaccine development is only part of the approach to global health security. It also requires:
- strong surveillance systems to identify emerging pathogens.
- fast and accurate diagnostic tests of new cases.
- emergency operation centers to co-ordinate an effective response.
by updating production with the genetic sequence
If standardized "plug-and-play" vaccines platforms are created, researchers could build assembly-line plants around the world to develop them.
Production costs could drop dramatically as companies and governments wouldn't need to invest in new plants for each new vaccine.
In the next decade, new vaccines could be created in a matter of weeks or months rather than years